Annual report
3079.TEDINET S100OKMV
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 90
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥45.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥41.0bn | 2020-04-01 → 2021-03-31 | Standalone | Net sales |
| Revenue | ¥44.7bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥40.4bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥38.3bn | 2017-04-01 → 2018-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Operating income | ¥847m | 2020-04-01 → 2021-03-31 | Standalone | Operating income |
| Ordinary income | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥851m | 2020-04-01 → 2021-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2017-04-01 → 2018-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥1.3bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥845m | 2020-04-01 → 2021-03-31 | Standalone | Income before income taxes |
| Net income | ¥863m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥572m | 2020-04-01 → 2021-03-31 | Standalone | Profit loss |
| Net income | ¥792m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥974m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥856m | 2017-04-01 → 2018-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥22.2bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥20.6bn | at 2021-03-31 | Standalone | Assets |
| Total assets | ¥20.4bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥18.6bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥17.6bn | at 2018-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥13.6bn | at 2022-03-31 | Standalone | Liabilities |
| Total liabilities | ¥12.6bn | at 2021-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥8.6bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.9bn | at 2021-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.6bn | at 2020-03-31d | Standalone | Net assets |
| Net assets / equity | ¥7.5bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥7.4bn | at 2018-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥7.8bn | at 2022-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥6.5bn | at 2021-03-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥7.8bn | at 2022-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2021-03-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥5.2bn | at 2020-03-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥5.3bn | at 2019-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥6.1bn | at 2018-03-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.7bn | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.7bn | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥290m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥97m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥217m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥362m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥195m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥267m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥235m | 2021-04-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥274m | 2020-04-01 → 2021-03-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥747m | 2019-04-01 → 2020-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥910m | 2018-04-01 → 2019-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥216m | 2017-04-01 → 2018-03-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥83.56 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.6 | 2020-04-01 → 2021-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.56 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥88.46 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥75.92 | 2017-04-01 → 2018-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥83.33 | 2021-04-01 → 2022-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥55.5 | 2020-04-01 → 2021-03-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥25 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2020-04-01 → 2021-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥23 | 2017-04-01 → 2018-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥828.27 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥767.76 | at 2021-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥735.76 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥689.18 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥653.64 | at 2018-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 38.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2021-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.1% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.8% | at 2018-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 10.5% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 7.4% | 2020-04-01 → 2021-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 13.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.1% | 2017-04-01 → 2018-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 10,780,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 10,780,000 | at 2021-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,280,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,280,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 11,280,000 | at 2018-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 328 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 330 | at 2021-03-31 | Standalone | Number of employees |
| Employees | 322 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 302 | at 2019-03-31d | Standalone | Number of employees |
| Employees | 284 | at 2018-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 17
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2021-04-01 → 2022-03-31 | ¥2.9bn |
| Arrhythmia Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥39.4bn |
| Arrhythmia Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥39.4bn |
| Ischemia Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| Ischemia Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥3.2bn |
| —segment total | revenue | 2021-04-01 → 2022-03-31 | ¥42.6bn |
| —segment total | revenue external | 2021-04-01 → 2022-03-31 | ¥42.6bn |
| Total Of Reportable Segments And Otherssegment total | employees | at 2022-03-31 | 328 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2020-04-01 → 2021-03-31 | ¥2.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2020-04-01 → 2021-03-31 | ¥2.6bn |
| Arrhythmia Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥35.3bn |
| Arrhythmia Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥35.3bn |
| Ischemia Businessreportable segment | revenue | 2020-04-01 → 2021-03-31 | ¥3.2bn |
| Ischemia Businessreportable segment | revenue external | 2020-04-01 → 2021-03-31 | ¥3.2bn |
| —segment total | revenue | 2020-04-01 → 2021-03-31 | ¥38.5bn |
| —segment total | revenue external | 2020-04-01 → 2021-03-31 | ¥38.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 943
| Item | Context | Value | Unit |
|---|---|---|---|
| Trade notes receivable transferred by endorsement | CurrentYearInstant_NonConsolidatedMember | 131987000 | JPY |
| Write downs of inventories | Prior1YearDuration_NonConsolidatedMember | -1638000 | JPY |
| Write downs of inventories | CurrentYearDuration_NonConsolidatedMember | 2587000 | JPY |
| Salaries and allowances sga | Prior1YearDuration_NonConsolidatedMember | 1536881000 | JPY |
| Salaries and allowances sga | CurrentYearDuration_NonConsolidatedMember | 1513154000 | JPY |
| Bonuses and provision for bonuses sga | Prior1YearDuration_NonConsolidatedMember | 521311000 | JPY |
| Bonuses and provision for bonuses sga | CurrentYearDuration_NonConsolidatedMember | 551484000 | JPY |
| Provision for directors retirement benefits sga | Prior1YearDuration_NonConsolidatedMember | 2042000 | JPY |
| Provision for directors retirement benefits sga | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Retirement benefit expenses sga | Prior1YearDuration_NonConsolidatedMember | 69843000 | JPY |
| Retirement benefit expenses sga | CurrentYearDuration_NonConsolidatedMember | 77813000 | JPY |
| Depreciation sga | Prior1YearDuration_NonConsolidatedMember | 200955000 | JPY |
| Depreciation sga | CurrentYearDuration_NonConsolidatedMember | 158889000 | JPY |
| Research and development expenses sga | Prior1YearDuration_NonConsolidatedMember | 28022000 | JPY |
| Research and development expenses sga | CurrentYearDuration_NonConsolidatedMember | 7926000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentsMember | 35254826000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentsMember | 3197615000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember | 38452442000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2554566000 | JPY |
| Revenues from external customers | Prior1YearDuration_NonConsolidatedMember | 41007008000 | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentsMember | 35254826000 | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentsMember | 3197615000 | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember | 38452442000 | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2554566000 | JPY |
| Net sales | Prior1YearDuration_NonConsolidatedMember | 41007008000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentsMember | 3911895000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentsMember | 714706000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember_ReportableSegmentsMember | 4626601000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 330407000 | JPY |
| Gross profit | Prior1YearDuration_NonConsolidatedMember | 4957009000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentsMember | 39374717000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentsMember | 3185952000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 42560670000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2935604000 | JPY |
| Revenues from external customers | CurrentYearDuration_NonConsolidatedMember | 45496274000 | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYearDuration_NonConsolidatedMember | － | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000ArrhythmiaBusinessReportableSegmentsMember | 39374717000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_jpcrp030000-asr_E03005-000IschemiaBusinessReportableSegmentsMember | 3185952000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_ReportableSegmentsMember | 42560670000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 2935604000 | JPY |
| Net sales | CurrentYearDuration_NonConsolidatedMember | 45496274000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |